KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Common Equity (2016 - 2025)

Colgate Palmolive (CL) has 17 years of Common Equity data on record, last reported at $54.0 million in Q4 2025.

  • For Q4 2025, Common Equity fell 74.53% year-over-year to $54.0 million; the TTM value through Dec 2025 reached $54.0 million, down 74.53%, while the annual FY2025 figure was $54.0 million, 74.53% down from the prior year.
  • Common Equity reached $54.0 million in Q4 2025 per CL's latest filing, down from $1.2 billion in the prior quarter.
  • Across five years, Common Equity topped out at $24.6 billion in Q3 2023 and bottomed at -$26.0 billion in Q4 2023.
  • Average Common Equity over 5 years is $1.7 billion, with a median of $1.2 billion recorded in 2025.
  • Peak YoY movement for Common Equity: surged 146700.0% in 2021, then tumbled 2601600.0% in 2023.
  • A 5-year view of Common Equity shows it stood at $1.5 billion in 2021, then plummeted by 100.07% to -$1.0 million in 2022, then crashed by 2601600.0% to -$26.0 billion in 2023, then skyrocketed by 100.81% to $212.0 million in 2024, then tumbled by 74.53% to $54.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $54.0 million in Q4 2025, $1.2 billion in Q3 2025, and $1.5 billion in Q2 2025.